Invasive brain-computer interfaces are demonstrating long-term commercial potential, with companies like Neuralink, Synchron, and Science developing applications for controlling computers and robotic arms, operating iPads, and assisting visually impaired patients.
Invasive BCI technologies show long-term commercial promise
Invasive brain-computer interfaces show long-term commercial potential for controlling computers, operating iPads, and assisting visually impaired patients
